Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase III, Multi-center Study to Evaluate the Safety and Efficacy of Epithelium-on Corneal Collagen Cross-linking in Eyes With Progressive Keratoconus

Trial Profile

A Phase III, Multi-center Study to Evaluate the Safety and Efficacy of Epithelium-on Corneal Collagen Cross-linking in Eyes With Progressive Keratoconus

Status: Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 13 Jun 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Riboflavin (Primary)
  • Indications Keratoconus
  • Focus Registrational; Therapeutic Use
  • Sponsors Avedro
  • Most Recent Events

    • 02 May 2019 Status changed from recruiting to active, no longer recruiting.
    • 05 Apr 2018 Status changed from not yet recruiting to recruiting.
    • 15 Mar 2018 According to an Avedro media release, if trial objectives met this study would form the primary basis of a regulatory submission to obtain FDA approval of Avedros epi-on cross-linking treatment.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top